Cyclophosphamide Treatment Options

A collection of 2150 research studies where Cyclophosphamide is the interventional treatment. These studies are located in the United States. Cyclophosphamide is used for conditions such as Breast Cancer, Lymphoma and Leukemia.

Home

All Treatments

Cyclophosphamide

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

Featured Trial

Paid Clinical Studies Nationwide

Recruiting

Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.

Conditions:

Healthy

Healthy Volunteer Study

Learn More

* Compensation for time may be available

Featured Trial

Type 2 Diabetes Clinical Trial

Recruiting

Can changing your breakfast improve your type 2 diabetes? If you have an HbA1C of 7.0% or higher, you are invited to participate in an online study at the University of Michigan.

Conditions:

Type 2 Diabetes

Diabetes Mellitus Type 2 in Obese

Diabetes Type Two

Type 2 Diabetes Mellitus

Diabete Type 2

Learn More

Featured Offer

Lose Weight with GLP-1 Medications

Recruiting

Policy Lab has partnered with CareGLP to offer trusted access to GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.

GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.

As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.

Conditions:

Overweight

Overweight and Obesity

Obesity

Weight Loss

Morbid Obesity

Learn More

NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders

NCT00053989

Completed

RATIONALE: Giving low doses of chemotherapy before a donor peripheral blood stem cell transplant helps stop the growth of cancer cells. It also stops the patient's immune system from rejecting the donor's stem cells. The donated stem cells may replace the patient's immune system and help destroy any remaining cancer cells (graft-versus-tumor effect). Giving an infusion of the donor's T cells (donor lymphocyte infusion) after the transplant may help increase this effect. Sometimes the transplante... Read More

Gender:

ALL

Ages:

Between 4 years and 75 years

Trial Updated:

01/29/2020

Locations: Roswell Park Cancer Institute, Buffalo, New York

Conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases, Fanconi Anemia, Aplastic Anemia

Learn More ›

BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL)

NCT00088530

Completed

BBR 2778 is a novel aza-anthracenedione that has activity in experimental tumors and shows reduced potential for cardiotoxicity in animal models. This cytotoxic agent has structural similarities with mitoxantrone as well as general similarities with anthracyclines (such as the tricyclic central quinoid chromophore).

Gender:

ALL

Ages:

18 years and above

Trial Updated:

01/27/2020

Locations: Robert A. Moss, M.D., FACP, Inc., Fountain Valley, California +98 locations

Robert A. Moss, M.D., FACP, Inc., Fountain Valley, California

UCLA Medical Center, Los Angeles, California

Watson Clinic for Cancer Care and Research, Lakeland, Florida

Rush University Medical Center, Chicago, Illinois

New Mexico Oncology/Hematology, Albuquerque, New Mexico

SUNY Upstate Medical University, Syracuse, New York

Duke University Medical Center, Durham, North Carolina

Northwest Kaiser Permanente, Portland, Oregon

Northern Utah Hematology Oncology, P.C., Ogden, Utah

Clinica Modelo S.A., Parana, Entre Rios

Instituto de Investigaciones Clinicas, Rosario, Santa Fe

Centro Oncologico Rosario, Rosario, Santa Fe

FUNDALEU - fundacion para combatir le Leucernia, Buenos Aires, Not set

Hospital Universitario Austral, Buenos Aires, Not set

Academia Nacional de Medicina, Caba, Not set

Hospital Privado Centro Medico de Cordoba S.A., Cordoba, Not set

ISIS Clinica Especializada, Santa Fe, Not set

University Gernal Hospital for Active Treatment "Alexandrovska" - Clinic of Hematology, Sofia, Not set

National Centre for Hemotransfusion, Sofia, Not set

University General Hospital for Active Treatment "St. Marina" Clinic of Hematology, Varna, Not set

Hospital CIMA San Jose, Escazu, Not set

Hospital Oncologico de Solca, Capilla Mauta, Guayaquil

Hospital Carlos Andrade Marin Oncologia, Quito,, Pinchincha

Hospital Solca Quito, Quito, Not set

Tartu University Clinics, Hematology Oncology Clinic, Tartu, Not set

Institute Bergonie, Bordeaux, Not set

Centre Hospitalier Lyo Sud, Service d'Hematologie et d'Oncologie, Pierre-Benite, Not set

Hopitaux Universitaires de Strabourg - Hopital de Hautepierre, Strasbourg, Not set

Staedtische Kliniken Hoechst, Frankfurt, HE

Charite, Campus Benjamin Franklin, Berlin, Not set

Universitatklinik des Saarlandes, Innere Medzin I, Hamburg, Not set

Westpfalzklinikum Kaiserslautern, Kaiserslautern, Not set

Klinikum der Universitaet zu Koeln, Koeln, Not set

Kliniken Maria Hilf GmbH, Moenchengladbach, Not set

Mutterhaus der Borromaeerinne, Trier, Not set

Szent Laszlo Korhaz, Budapest, Not set

Petz Aladar Megyei Okato Korhaz, Gyor, Not set

Bekes Megyei Pandy Kalman Korhaz, Gyula, Not set

Kaposi Mor Megyei Korhaz, Kaposvar, Not set

Pecsi Tudomanyegyetem, Pecs, Not set

Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Orvos-es Gyogy II, Szeged, Not set

Indo-American Cancer Institute & Research Center, Hyderabaad, AndhPrad

Nizam's Institute of Medical Sciences, Panjagutta, Hyderabad

Manipal Hospital, Bangalore, Karnataka

Shirdi Sai Baba Cancer Hospital, K.M.C. Manipal, Manipala, Karna

Regional Cancer Center, Thiruvananthapuram, Kerla

Bhagwan Mahaveer Cancer Hospital & Research Center, Jaipur, Rajasthan

M.S. Ramaiah Medical College, Bangalore, Not set

Tata Memorial Hospital, Mumbai, Not set

Policlinico S. Orsola, Instituto di Ematologia, Bologna, Not set

Ospedale Oncologico "A. Businco", Cagliari, Not set

Ospedale S. Martino, Genova, Not set

Universita degli Studi Perugia Policlinico Monteluce, Perugia, Not set

Azienda ospedaliera Pisana "Santa Chiara", Pisa, Not set

Azienda Ospedaliera Pisanan "Santana Chiara", Pisa, Not set

Ospedale Oncolgoico Regionale della Basilicata, Rionero in Vulture, Not set

Ospedale S. Eugenio, Roma, Not set

Universita La Sapienza, Roma, Not set

Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo, Not set

Policlinico S. Maria alle Scotte, Siena, Not set

Presidio San Giuseppe Moscati, Taranto, Not set

Ospedale Civile, Udine, Not set

Fundacion Centro De Investigacion, Medellin, Columbia

Medical Solutions, Guatimala, Guatemala

Complejo Hospitalario "Arnulfo Arias Madrid, Panama, Not set

Hospital Edgardo Rebagliati Martins, Lima, Not set

Onococenter, San Borja, Not set

Klinika Hematologii, Onkologii i Chorob Wewnetrznych, Gdansk, Not set

Brasov Counthy Hospital, Brasov, Not set

Colentina Clinical Hospital Hem Dept, Bucharest, Not set

Fundei Clinical Institute, Bucharest, Not set

Prof. Dr. Ian Chiricuta, Institute of Oncology, Radiotheraphy, Cluj Napoca, Not set

Institutul Oncologic "Ion Chiricuta" Oncologie Medicala, Cluj-Napoca, Not set

Mures County Clinical Hospital, Targu Mures, Not set

State Medical Institution Altai Territorial Oncological Center, Barnaul, Not set

State Medical Institution Replubican Oncological Center, Bashkortostan, Not set

State Therapeutical & Prophlatic Institution: Cheylabinsk Regional Oncological Center, Chelyabinsk, Not set

State Medical Institution, Irkutsk, Not set

State Medical Institution: Clinical Oncological Center, Krasnodar, Not set

Russian Oncological Research Center n.a. N.N. Blokhin, Moscow, Not set

State Institution: Hematological Research Center under the Russian Academy of Medical Sciences, Moscow, Not set

State Institution: Moscow Regional Research Clinical institute n.a. M.F., Moscow, Not set

Semashko Central Clinical Hospital, Moscow, Not set

Medical Radiological Research Center under the Russian academey of Medical Sciences, Obninsk, Not set

Research Insitute of Hematology and Blood Transfusion, St. Petersburg, Not set

St. Petersburg Pavlov State Medical Clinic of Intensive Care & Bone Marrow Transplantation, St. Petersburg, Not set

St. Petersburg State Medical univ. n.a. I.P. Pavlov, St. Petersburg, Not set

St. Petersburg State Medical Institution: Municipal Hospital #31, St. Petersburg, Not set

Central Research Rontgenological and Radiological Institute, St. Petersburg, Not set

State Research Institution: Research Institute of Oncology, St. Petersburg, Not set

Institute of Clinical Radiology of the Research Center for Radiation Medicine under the UAMS, Kyiv, Not set

Kyiv Bone Marrow Transplantation, Kyiv, Not set

Institute of Blood Pathology & Transfusion Medicine under the UAMS, Lviv, Not set

Zhtomyr O.F. Gerbachevsky Regional Hospital, Zhytomyr, Not set

Beatson Oncology Centre, Western Infirmary, Glasgow, Not set

St. Georges Hospital, London, Not set

Weston Park Hospital, Sheffield, Not set

Hospital Maciel, Montevideo, Not set

Hospital Policial de Montevideo, Poblado Montevideo Chico, Not set

Conditions: Lymphoma, Non-Hodgkin

Learn More ›

A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer

NCT02117024

Terminated

Determine whether viagenpumatucel-L combined with low-dose cyclophosphamide prolongs survival in patients with NSCLC who failed 2 or 3 prior lines of therapy for incurable or metastatic disease compared with chemotherapy alone.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

01/24/2020

Locations: Highlands Oncology Group, Rogers, Arkansas +15 locations

Conditions: Non Small Cell Lung Cancer

Learn More ›

Study of REGN2810 (Anti-PD-1) in Patients With Advanced Malignancies

NCT02383212

Completed

This is a phase 1, open-label, multicenter, ascending-dose escalation study of cemiplimab, alone and in combination with other anti-cancer therapies in patients with advanced malignancies.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

01/23/2020

Locations: Banner MD Anderson Cancer Center, Gilbert, Arizona +46 locations

Banner MD Anderson Cancer Center, Gilbert, Arizona

Western Regional Medical Center, Goodyear, Arizona

Mayo Clinic, Phoenix, Arizona

University of Arizona Cancer Center, Tucson, Arizona

City of Hope National Medical Center, Duarte, California

The Angeles Clinic and Research Institute, Los Angeles, California

Ronald Reagan UCLA Medical Center, Los Angeles, California

Stanford University, Stanford, California

Sarah Cannon Research Institute at HealthONE, Denver, Colorado

Norwalk Hospital, Norwalk, Connecticut

Georgetown University Medical Center, Washington, District of Columbia

H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida

Winship Cancer Institute, Emory University, Atlanta, Georgia

University of Chicago, Chicago, Illinois

Indiana University, Indianapolis, Indiana

University of Kansas Cancer Center, Fairway, Kansas

Dana Farber Cancer Institute, Boston, Massachusetts

Barbara Ann Karmanos Cancer Center, Detroit, Michigan

Washington University School of Medicine Siteman Cancer Center, Saint Louis, Missouri

Nebraska Methodist Hospital, Omaha, Nebraska

Hackensack University Medical Center, Hackensack, New Jersey

Cancer Institute of New Jersey, New Brunswick, New Jersey

Columbia University Medical Center, New York, New York

Laura & Isaac Perlmutter Cancer Center, New York, New York

Mount Sinai Medical Center, New York, New York

Weill Cornell Medical College, New York, New York

Duke Cancer Institute, Durham, North Carolina

University Hospitals Case Medical Center, Cleveland, Ohio

Stephenson Cancer Center, Oklahoma City, Oklahoma

Providence Portland Medical Center, Portland, Oregon

Penn State Milton S Hershey Medical Center, Hershey, Pennsylvania

University of Pittsburgh Medical Center Shadyside, Pittsburgh, Pennsylvania

Miriam Hospital, Providence, Rhode Island

Sarah Cannon Research Institute, Nashville, Tennessee

Vanderbilt University Medical Center, Nashville, Tennessee

Mary Crowley Cancer Research Center - Medical City, Dallas, Texas

Baylor College of Medicine, Houston, Texas

The University of Texas MD Anderson Cancer Center, Houston, Texas

START South Texas Accelerated Research Therapeutics, San Antonio, Texas

Northwest Medical Specialties, Tacoma, Washington

Peter Maccallum Cancer Centre, Melbourne, Not set

Institut Catala d'Oncologia L'hospitalet, L'Hospitalet de Llobregat, Barcelona

Hospital Universitario Vall d'Hebron, Barcelona, Not set

Fundacion Jimenez Diaz, Madrid, Not set

Hospital Universitario HM Sanchinarro-CIOCC, Madrid, Not set

Hospital Universitario Ramon y Cajal, Madrid, Not set

MD Anderson Cancer Center, Madrid, Not set

Conditions: Advanced Cancer, Advanced Malignancies

Learn More ›

Lenalidomide and Dexamethasone With/Without Stem Cell Transplant in Patients With Multiple Myeloma

NCT01731886

Completed

The study is being done to compare the combination of lenalidomide and dexamethasone followed by autologous peripheral blood stem cell transplant (PBSCT) and lenalidomide and dexamethasone without PBSCT in patients with untreated multiple myeloma. This comparison will include how the subjects respond to each study treatment combination, and what side effects are caused by each combination.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

01/21/2020

Locations: Columbia University, New York, New York

Conditions: Multiple Myeloma

Learn More ›

Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma Patients

NCT00038142

Terminated

Objectives: 1. To determine if dose intensive Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) with or without ImmTherTM can improve the 2-year disease-free survival seen with standard VAC therapy. 2. To evaluate the feasibility and describe the toxicity associated with VACdxr. 3. To evaluate the feasibility and describe the toxicity of administering ImmTherTM on a weekly basis for 50- 52 weeks. 4. To determine which therapy (VACdxr+ or VACdxr-) is worthy of further evaluatio... Read More

Gender:

ALL

Ages:

Between 3 years and 60 years

Trial Updated:

01/17/2020

Locations: University of Texas MD Anderson Cancer Center, Houston, Texas

Conditions: Ewing's Sarcoma

Learn More ›

Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant, Mycophenolate Mofetil, and Cyclosporine in Treating Patients With Fanconi Anemia

NCT00453388

Completed

This phase II trial studies how well total-body irradiation (TBI) works when given together with fludarabine phosphate and cyclophosphamide followed by donor bone marrow transplant, mycophenolate mofetil, and cyclosporine in treating patients with Fanconi anemia (FA). Giving low doses of chemotherapy, such as fludarabine phosphate and cyclophosphamide, and TBI before or after a donor bone marrow transplant helps stop the growth of abnormal cells. It may also stop the patient's immune system from... Read More

Gender:

ALL

Ages:

All

Trial Updated:

01/17/2020

Locations: Children's Hospital and Research Center at Oakland, Oakland, California +4 locations

Conditions: Acute Myeloid Leukemia in Remission, de Novo Myelodysplastic Syndrome, Fanconi Anemia, Previously Treated Myelodysplastic Syndrome

Learn More ›

Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoma

NCT00005803

Completed

This phase I/II trial studies how well autologous stem cell transplant followed by donor stem cell transplant works in treating patients with lymphoma that has returned or does not respond to treatment. Peripheral blood stem cell transplant using stem cells from the patient or a donor may be able to replace immune cells that were destroyed by chemotherapy used to kill cancer cells. The donated stem cells may also help destroy any remaining cancer cells (graft-versus-tumor effect).

Gender:

ALL

Ages:

75 years and below

Trial Updated:

01/17/2020

Locations: Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah +4 locations

Conditions: Prolymphocytic Leukemia, Recurrent Adult Hodgkin Lymphoma, Recurrent Childhood Hodgkin Lymphoma, Recurrent Childhood Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent Non-Hodgkin Lymphoma, Recurrent Small Lymphocytic Lymphoma, Refractory Childhood Hodgkin Lymphoma, Refractory Chronic Lymphocytic Leukemia, Refractory Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Refractory Small Lymphocytic Lymphoma, T-Cell Chronic Lymphocytic Leukemia, T-Cell Prolymphocytic Leukemia

Learn More ›

Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer

NCT00789776

Completed

This phase I/II trial studies the side effects and best dose of donor natural killer (NK) cell therapy and to see how well it works when given together with fludarabine phosphate, cyclophosphamide, total-body irradiation, donor bone marrow transplant, mycophenolate mofetil, and tacrolimus in treating patients with hematologic cancer. Giving chemotherapy, such as fludarabine phosphate and cyclophosphamide, and total-body irradiation before a donor bone marrow transplant helps stop the growth of c... Read More

Gender:

ALL

Ages:

All

Trial Updated:

01/15/2020

Locations: Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington +2 locations

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma, Previously Treated Myelodysplastic Syndrome, Recurrent Chronic Lymphocytic Leukemia, Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Recurrent Indolent Adult Non-Hodgkin Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Plasma Cell Myeloma, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia, Refractory Hodgkin Lymphoma, Refractory Plasma Cell Myeloma, Refractory Small Lymphocytic Lymphoma, Waldenstrom Macroglobulinemia

Learn More ›

High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma

NCT00354744

Completed

RATIONALE: Drugs used in chemotherapy, such as vincristine, irinotecan, ifosfamide, etoposide, doxorubicin, cyclophosphamide, and dactinomycin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Radiation therapy uses high-energy x-rays to kill tumor cells. Giving high-dose combination chemotherapy together with radiation therapy may kill more tumor cells. PURPOSE: This phase III trial is studying how well giving high-dose co... Read More

Gender:

ALL

Ages:

49 years and below

Trial Updated:

01/15/2020

Locations: Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham, Birmingham, Alabama +165 locations

Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham, Birmingham, Alabama

Phoenix Children's Hospital, Phoenix, Arizona

Arizona Cancer Center at University of Arizona Health Sciences Center, Tucson, Arizona

Arkansas Cancer Research Center at University of Arkansas for Medical Sciences, Little Rock, Arkansas

Southern California Permanente Medical Group, Downey, California

Loma Linda University Cancer Institute at Loma Linda University Medical Center, Loma Linda, California

Jonathan Jaques Children's Cancer Center at Miller Children's Hospital, Long Beach, California

Childrens Hospital Los Angeles, Los Angeles, California

Children's Hospital Central California, Madera, California

Children's Hospital and Research Center Oakland, Oakland, California

Children's Hospital of Orange County, Orange, California

Sutter Cancer Center, Sacramento, California

University of California Davis Cancer Center, Sacramento, California

Kaiser Permanente Medical Center - Oakland, Sacramento, California

Rady Children's Hospital - San Diego, San Diego, California

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California

Stanford Cancer Center, Stanford, California

Children's Hospital Center for Cancer and Blood Disorders, Aurora, Colorado

Carole and Ray Neag Comprehensive Cancer Center at the University of Connecticut Health Center, Farmington, Connecticut

Alfred I. duPont Hospital for Children, Wilmington, Delaware

Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, Washington, District of Columbia

Children's National Medical Center, Washington, District of Columbia

Walter Reed Army Medical Center, Washington, District of Columbia

Broward General Medical Center Cancer Center, Fort Lauderdale, Florida

Lee Cancer Care of Lee Memorial Health System, Fort Myers, Florida

University of Florida Shands Cancer Center, Gainesville, Florida

Memorial Cancer Institute at Memorial Regional Hospital, Hollywood, Florida

Nemours Children's Clinic, Jacksonville, Florida

Miami Children's Hospital, Miami, Florida

Baptist-South Miami Regional Cancer Program, Miami, Florida

Florida Hospital Cancer Institute at Florida Hospital Orlando, Orlando, Florida

M.D. Anderson Cancer Center at Orlando, Orlando, Florida

Nemours Children's Clinic - Orlando, Orlando, Florida

Sacred Heart Cancer Center at Sacred Heart Hospital, Pensacola, Florida

All Children's Hospital, Saint Petersburg, Florida

St. Joseph's Cancer Institute at St. Joseph's Hospital, Tampa, Florida

Kaplan Cancer Center at St. Mary's Medical Center, West Palm Beach, Florida

Winship Cancer Institute of Emory University, Atlanta, Georgia

MBCCOP - Medical College of Georgia Cancer Center, Augusta, Georgia

Curtis and Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center, Savannah, Georgia

Cancer Research Center of Hawaii, Honolulu, Hawaii

University of Illinois Cancer Center, Chicago, Illinois

Children's Memorial Hospital - Chicago, Chicago, Illinois

University of Chicago Cancer Research Center, Chicago, Illinois

Advocate Christ Medical Center, Oak Lawn, Illinois

Advocate Lutheran General Cancer Care Center, Park Ridge, Illinois

Saint Jude Midwest Affiliate, Peoria, Illinois

Simmons Cooper Cancer Institute, Springfield, Illinois

Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana

St. Vincent Indianapolis Hospital, Indianapolis, Indiana

Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center, Kansas City, Kansas

Lucille P. Markey Cancer Center at University of Kentucky, Lexington, Kentucky

Kosair Children's Hospital, Louisville, Kentucky

Tulane Cancer Center Office of Clinical Research, Alexandria, Louisiana

Children's Hospital of New Orleans, New Orleans, Louisiana

Alvin and Lois Lapidus Cancer Institute at Sinai Hospital, Baltimore, Maryland

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland

Floating Hospital for Children at Tufts - New England Medical Center, Boston, Massachusetts

Massachusetts General Hospital, Boston, Massachusetts

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston, Massachusetts

C.S. Mott Children's Hospital at University of Michigan Medical Center, Ann Arbor, Michigan

Barbara Ann Karmanos Cancer Institute, Detroit, Michigan

Hurley Medical Center, Flint, Michigan

Butterworth Hospital at Spectrum Health, Grand Rapids, Michigan

CCOP - Kalamazoo, Kalamazoo, Michigan

Breslin Cancer Center at Ingham Regional Medical Center, Lansing, Michigan

Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis, Minnesota

University of Minnesota Cancer Center, Minneapolis, Minnesota

Mayo Clinic Cancer Center, Rochester, Minnesota

University of Mississippi Cancer Clinic, Jackson, Mississippi

Children's Mercy Hospital, Kansas City, Missouri

Siteman Cancer Center at Barnes-Jewish St. Peters Hospital - Saint Louis, Saint Louis, Missouri

Children's Hospital, Omaha, Nebraska

UNMC Eppley Cancer Center at the University of Nebraska Medical Center, Omaha, Nebraska

Sunrise Hospital and Medical Center, Las Vegas, Nevada

Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire

Hackensack University Medical Center Cancer Center, Hackensack, New Jersey

Overlook Hospital, Morristown, New Jersey

Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick, New Jersey

Newark Beth Israel Medical Center, Newark, New Jersey

St. Joseph's Hospital and Medical Center, Paterson, New Jersey

University of New Mexico Cancer Center, Albuquerque, New Mexico

Albany Medical Center Hospital, Albany, New York

Roswell Park Cancer Institute, Buffalo, New York

Schneider Children's Hospital, New Hyde Park, New York

NYU Cancer Institute at New York University Medical Center, New York, New York

Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center, New York, New York

James P. Wilmot Cancer Center at University of Rochester Medical Center, Rochester, New York

Stony Brook University Cancer Center, Stony Brook, New York

SUNY Upstate Medical University Hospital, Syracuse, New York

New York Medical College, Valhalla, New York

Mission Hospitals - Memorial Campus, Asheville, North Carolina

Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina

Blumenthal Cancer Center at Carolinas Medical Center, Charlotte, North Carolina

Presbyterian Cancer Center at Presbyterian Hospital, Charlotte, North Carolina

Duke Comprehensive Cancer Center, Durham, North Carolina

Wake Forest University Comprehensive Cancer Center, Winston-Salem, North Carolina

Akron Children's Hospital, Akron, Ohio

Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio

Rainbow Babies and Children's Hospital, Cleveland, Ohio

Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio

Nationwide Children's Hospital, Columbus, Ohio

Children's Medical Center - Dayton, Dayton, Ohio

Toledo Hospital, Toledo, Ohio

Medical University of Ohio Cancer Center, Toledo, Ohio

Oklahoma University Cancer Institute, Oklahoma City, Oklahoma

Oregon Health and Science University Cancer Institute, Portland, Oregon

Lehigh Valley Hospital - Muhlenberg, Bethlehem, Pennsylvania

Geisinger Cancer Institute at Geisinger Health, Danville, Pennsylvania

Penn State Cancer Institute at Milton S. Hershey Medical Center, Hershey, Pennsylvania

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania

Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania

Hollings Cancer Center at Medical University of South Carolina, Charleston, South Carolina

Palmetto Health South Carolina Cancer Center, Columbia, South Carolina

Greenville Hospital Cancer Center, Greenville, South Carolina

Sanford Cancer Center at Sanford USD Medical Center, Sioux Falls, South Dakota

T.C. Thompson Children's Hospital, Chattanooga, Tennessee

East Tennessee Children's Hospital, Knoxville, Tennessee

St. Jude Children's Research Hospital, Memphis, Tennessee

Vanderbilt-Ingram Cancer Center, Nashville, Tennessee

Texas Tech University Health Sciences Center School of Medicine - Amarillo, Amarillo, Texas

Dell Children's Medical Center of Central Texas, Austin, Texas

Driscoll Children's Hospital, Corpus Christi, Texas

Medical City Dallas Hospital, Dallas, Texas

Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas, Dallas, Texas

Cook Children's Medical Center - Fort Worth, Fort Worth, Texas

Baylor University Medical Center - Houston, Houston, Texas

M. D. Anderson Cancer Center at University of Texas, Houston, Texas

Covenant Children's Hospital, Lubbock, Texas

University of Texas Health Science Center at San Antonio, San Antonio, Texas

Methodist Children's Hospital of South Texas, San Antonio, Texas

CCOP - Scott and White Hospital, Temple, Texas

Primary Children's Medical Center, Salt Lake City, Utah

Fletcher Allen Health Care - University Health Center Campus, Burlington, Vermont

Inova Fairfax Hospital, Falls Church, Virginia

Children's Hospital of The King's Daughters, Norfolk, Virginia

Carilion Medical Center for Children at Roanoke Community Hospital, Roanoke, Virginia

Children's Hospital and Regional Medical Center - Seattle, Seattle, Washington

Providence Cancer Center at Sacred Heart Medical Center, Spokane, Washington

Mary Bridge Children's Hospital and Health Center - Tacoma, Tacoma, Washington

West Virginia University Health Sciences Center - Charleston, Charleston, West Virginia

Marshfield Clinic - Marshfield Center, Marshfield, Wisconsin

Midwest Children's Cancer Center, Milwaukee, Wisconsin

John Hunter Hospital, Newcastle, New South Wales

Westmead Institute for Cancer Research at Westmead Hospital, Westmead, New South Wales

Royal Children's Hospital, Herston, Brisbane, Queensland

Women's and Children's Hospital, North Adelaide, South Australia

Royal Children's Hospital, Parkville, Victoria

Princess Margaret Hospital for Children, Perth, Western Australia

Alberta Children's Hospital, Calgary, Alberta

University of Alberta Hospital, Edmonton, Alberta

Children's & Women's Hospital of British Columbia, Vancouver, British Columbia

CancerCare Manitoba, Winnipeg, Manitoba

Janeway Children's Health and Rehabilitation Centre, St. John's, Newfoundland and Labrador

IWK Health Centre, Halifax, Nova Scotia

McMaster Children's Hospital at Hamilton Health Sciences, Hamilton, Ontario

Cancer Centre of Southeastern Ontario at Kingston General Hospital, Kingston, Ontario

Children's Hospital of Western Ontario, London, Ontario

Children's Hospital of Eastern Ontario, Ottawa, Ontario

Hospital for Sick Children, Toronto, Ontario

Montreal Children's Hospital at McGill University Health Center, Montreal, Quebec

Hopital Sainte Justine, Montreal, Quebec

Saskatoon Cancer Centre at the University of Saskatchewan, Saskatoon, Saskatchewan

Centre Hospitalier Universitaire de Quebec, Quebec, Not set

San Jorge Children's Hospital, Santurce, Not set

Swiss Pediatric Oncology Group Bern, Bern, Not set

Conditions: Sarcoma

Learn More ›

Anti-Human CD45 Monoclonal Antibodies in Patients With Advanced Leukemia Prior to Allogeneic Stem Cell Transplantation

NCT00057005

Completed

Participants in this study have a hematologic malignancy which is a disorder in the bone marrow that affects the body's ability to create blood. Participants might benefit from receiving an allogeneic stem cell transplant (meaning the cells come from a donor). The participants donor is a family member. Stem cells are cells in the bone marrow and blood that can form a whole new blood system.

Gender:

ALL

Ages:

45 years and below

Trial Updated:

01/15/2020

Locations: Texas Children's Hospital, Houston, Texas +1 locations

Conditions: LEUKEMIA

Learn More ›

Bone Marrow Transplant From Related Donor for Patients With High Risk Hemoglobinopathies

NCT00040469

Terminated

The major goal of this study is to determine the risks and benefits of bone marrow transplants in patients with severe thalassemia or sickle cell disease. Participation in this project will be for two years.

Gender:

ALL

Ages:

Between 1 day and 64 years

Trial Updated:

01/15/2020

Locations: Texas Children's Hospital, Houston, Texas +1 locations

Conditions: Sickle Cell Anemia, Hemoglobinopathy, Thalassemia

Learn More ›